BD2 Integrated Network

Overview

About this study

This research study is designed to fill gaps in our understanding of bipolar disorder. This study involves collecting information from participants to answer key questions relevant to bipolar disorder which might help change or improve the way we do things in the future. This is an observational study and does not involve any additional treatment beyond your standard care at the clinic.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18-75
  • Diagnosis of bipolar I disorder as per the Structured Clinical Interview for DSM-5 Disorders Research Version (SCID-5-RV)
  • Ability to provide written informed consen
  • Ability to understand and speak either English or Spanish
  • Mood and related symptoms that are stable enough to participate in the protocol based upon clinician’s/site investigator’s judgment.

Exclusion Criteria:

  • Any unstable medical disorder that, at the discretion of the site investigator, would substantially interfere with participation. This includes known progressive neurodegenerative disorders and dementing conditions, general medical conditions that are considered unstable based on clinician’s judgment. (e.g., metastatic cancers or other illnesses known to be directly affecting the central nervous system).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/23/24. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Balwinder Singh, M.D., M.S.

Open for enrollment

Contact information:

Laura Harper CCRP

(507) 255-9352

Harper.Laura1@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Osama Abulseoud, M.D.

Open for enrollment

Contact information:

Hayrunnisa Unlu M.D.

(480) 301-6071

Unlu.Hayrunnisa@mayo.edu

More information

Publications

Publications are currently not available